Tube-dilution MICs of seven 2-methyl-5-nitroimidazole compounds varying at the 1-substitution were determined against Bacteroides fragilis. Activities on a molar basis were ranked: tinidazole > panidazole > ornidazole > metronidazole 2 secnidazole > carnidazole > dimetridazole. Geometric mean MICs varied from 0.5 to 6.6 ,uM, and vulgatus, were within the range determined for B. fragilis.
Increased awareness of anaerobic infections and the demonstration of the excellent activity of metronidazole against a wide range of obligately anaerobic bacteria (4) (5) (6) 18) have raised new medical interest in nitroimidazole drugs. Other derivatives have subsequently been found to be active against Bacteroides fragilis and considered not essentially different from metronidazole (2, 3, 9, 12, 20) ; there has seemed to be little reason to look for alternatives. However, significant differences exist between closely related 5-nitroimidazole compounds ( Fig. 1 ) with respect to pharmacokinetics (10, 11, 13, 15, 21, 23, 24) , therapeutic results (13) , and mutagenicity (1, 17, 25) . Since such gradually accumulating information may cause reevaluations of the choice of drugs, we extended structure-activity investigations on the susceptibility of B. fragilis and report on a comparison of the seven 2-methyl-5-nitroimidazole derivatives which have reached clinical use (primarily in treating protozoal infections).
MATERIALS AND METHODS
Bacteria. We studied B. fragilis ATCC 23745 Inoculum. All work with the bacteria took place at room temperature inside an anaerobic chamber (model 800 anaerobic environmental system; Capco, Sunnyvale, Calif.), and the cultures were incubated at 37°C in transfer modules (model 830; Capco). All media were prereduced for 24 h or longer before use and not exposed to air before the end of the experiment. Stock cultures were checked for purity; a few fresh colonies were suspended in 1 ml of Schaedler broth (BBL Microbiology Systems, Cockeysville, Md.) and incubated for 24 h, after which the cultures in preliminary studies contained between 108 and 109 CFU/ml. For colony counting, cultures were diluted in water in 10-fold steps, and 0.1-ml samples were plated and incubated for 48 h. Similar 24-h cultures were diluted 1:104 in Schaedler broth to obtain inoculum suspensions for susceptibility tests, and the number of CFU in each inoculum was counted. 
a See the structure of the 2-methyl-5-nitroimidazole nucleus (Fig. 1 ).
ranging from 10-4 to 10-7 M were made in 1-ml volumes of
Schaedler broth, 1 ml of inoculum suspension was added, and the mixtures were vortexed and incubated for 24 h. MIC was the lowest drug concentration without visible turbidity. The seven nitroimidazoles were always studied in parallel, and the weekly choices of Bacteroides strains to be tested were randomized. The median of three MICs was recorded as the result. Statistical analysis. The logarithms of MICs were used in the calculation of correlation coefficients and in comparisons with the Student t test or the two-tailed paired-sample t test (30) .
RESULTS
According to earlier experience, the MICs of metronidazole, ornidazole, and tinidazole were essentially unaffected by increasing the inoculum concentration above the conventional 105 CFU/ml (12) , and the present 45 preliminary tests with 34 strains covered lower concentrations. The results with metronidazole appear in (Fig. 2) . Secnidazole did not differ from metronidazole; dimetridazole (P < 0.001 [paired-sample t test]) and carnidazole (P < 0.001) were less active; and ornidazole (P < 0.005), panidazole (P < 0.001), and tinidazole (P < 0.001) were more active than metronidazole. The extreme deviations from metronidazole with individual strains were 10-fold inferior activity (dimetridazole and carnidazole) and 50-fold superior activity (tinidazole) (Fig. 2) . Considering all drug pairs against a single bacterium at a time (results not shown), 50-fold different MICs were seen three times, 25-fold differences five times, and 20-fold differences three times. The accepted inocula ranged from 1.4 x 103 to 9.0 x 104 CFU, and the accepted MIC with each bacterium-drug combination was reproducible within 2 adjacent dilutions; i.e., it varied less than the MICs between strains. Despite wide scattering (Fig. 2) , the activities of all other drug pairs correlated significantly, but tinidazole-metronidazole and tinidazole-secnidazole behaved as unrelated pairs (Table 3) .
The MICs of the seven 2-methyl-5-nitroimidazoles against 14 non-B. fragilis members of the B. fragilis group (results not shown) fell, in all cases, within the respective range observed with B. fragilis. Table 4 shows the comparison of the seven compounds against B. fragilis ATCC 23745. The 16 clinical isolates tended to be more susceptible to each compound (Table 5) . Within the present series of 2-methyl-5-nitroimidazoles, with the exception of carnidazole, activity against B. fragilis seemed to increase with molecular weight, i.e., the size of the substitution at position 1 (Tables 1, 4 , and 5). This was true of the MICs expressed either as molar concentrations or on a weight basis (Tables 4 and 5 (12), or marginally less active than metronidazole (7). Our result agreed with the majority, confirming that the MICs of ornidazole are slightly lower than those of metronidazole. Tinidazole has been reported to equal ornidazole (29), but we confirmed our previous finding that tinidazole is more active than ornidazole (12) . Secnidazole has been found to be marginally more active than metronidazole (22) , although our MICs tended to show the opposite. Since secnidazole was the only compound which did not differ significantly from metronidazole in the present study, similar activity of these two nitroimidazoles is the unifying conclusion. The above four comparisons could be evaluated against reports from other laboratories, but our remaining 17 comparisons appear to be new and indicate the following order of decreasing activity: tinidazole > panidazole > ornidazole > metronidazole 2 secnidazole > carnidazole > dimetridazole. This order was based on MICs as molar concentrations, and the last two compounds change places if MICs are expressed in micrograms per milliliter. Molar concentrations may be more relevant in comparative evaluations, since the various biological activities of 5-nitroimidazoles depend on reduction of the nitro group, one per molecule (16, 17, 19) . This does not exclude the possibility that other parts of the molecule might also have antibacterial activity. In fact, one explanation for the poor or (1, (25) (26) (27) , i.e., very different and almost opposite to the other of antibacterial activity. The clinical significance of these comparisons is unknown. In light of the presently available information, metronidazole may still be sufficient to occupy first place among nitroimidazoles for treating anaerobic infections, but exceptions, like major differences in therapeutic outcome (13) associated with seemingly minor differences in vitro (14) , which have been documented in protozoal infections, may conceivably appear in bacterial 
